Is ELMD or BBNX more profitable?

Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of -61.31%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% Beta Bionics -61.31% -26.30% -23.25%

Does the media favor ELMD or BBNX?

In the previous week, Beta Bionics had 25 more articles in the media than Electromed. MarketBeat recorded 29 mentions for Beta Bionics and 4 mentions for Electromed. Electromed's average media sentiment score of 1.29 beat Beta Bionics' score of 0.17 indicating that Electromed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 8 Very Positive mention(s) 1 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, ELMD or INMD?

InMode has higher revenue and earnings than Electromed. InMode is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Electromed $73.78M 3.14 $5.15M $1.31 21.17 InMode $374.63M 2.29 $93.83M $1.23 12.14

Is ELMD or INMD more profitable?

InMode has a net margin of 20.69% compared to Electromed's net margin of 11.34%. Electromed's return on equity of 15.71% beat InMode's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% InMode 20.69% 11.99% 10.60%

Does the media favor ELMD or INMD?

In the previous week, Electromed had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for Electromed and 2 mentions for InMode. Electromed's average media sentiment score of 1.29 beat InMode's score of 0.81 indicating that Electromed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ELMD or SIBN?

Electromed has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Electromed $73.78M 3.14 $5.15M $1.31 21.17 SiBone $200.93M 4.12 -$18.90M -$0.34 N/A

Is ELMD or SIBN more profitable?

Electromed has a net margin of 11.34% compared to SiBone's net margin of -6.85%. Electromed's return on equity of 15.71% beat SiBone's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% SiBone -6.85% -8.23% -6.07%

Does the media prefer ELMD or SIBN?

In the previous week, SiBone had 2 more articles in the media than Electromed. MarketBeat recorded 6 mentions for SiBone and 4 mentions for Electromed. Electromed's average media sentiment score of 1.29 beat SiBone's score of 0.66 indicating that Electromed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AVR or ELMD?

In the previous week, Electromed had 2 more articles in the media than Anteris Technologies Global. MarketBeat recorded 4 mentions for Electromed and 2 mentions for Anteris Technologies Global. Electromed's average media sentiment score of 1.29 beat Anteris Technologies Global's score of 0.89 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Electromed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELMD or VREX?

In the previous week, Electromed had 1 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for Electromed and 3 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 1.77 beat Electromed's score of 1.29 indicating that Varex Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Varex Imaging 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Electromed (ELMD) Competitors

$27.73 +0.22 (+0.80%)

As of 10:17 AM Eastern

Compare

ELMD vs. BBNX, INMD, SIBN, AVR, and VREX

Should you buy Electromed stock or one of its competitors? Electromed's main competitors and comparable companies include Beta Bionics (BBNX), InMode (INMD), SiBone (SIBN), Anteris Technologies Global (AVR), and Varex Imaging (VREX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Electromed compare to Beta Bionics?

Electromed (NYSE:ELMD) and Beta Bionics (NASDAQ:BBNX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

40.8% of Electromed shares are owned by institutional investors. 10.5% of Electromed shares are owned by company insiders. Comparatively, 5.3% of Beta Bionics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of -61.31%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Beta Bionics	-61.31%	-26.30%	-23.25%

Electromed has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.37, indicating that its stock price is 237% more volatile than the broader market.

Electromed currently has a consensus target price of $43.75, suggesting a potential upside of 57.78%. Beta Bionics has a consensus target price of $20.10, suggesting a potential upside of 5.32%. Given Electromed's stronger consensus rating and higher probable upside, equities research analysts clearly believe Electromed is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Beta Bionics	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Beta Bionics had 25 more articles in the media than Electromed. MarketBeat recorded 29 mentions for Beta Bionics and 4 mentions for Electromed. Electromed's average media sentiment score of 1.29 beat Beta Bionics' score of 0.17 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beta Bionics	8 Very Positive mention(s)	1 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Electromed has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.14	$5.15M	$1.31	21.17
Beta Bionics	$119.01M	7.21	-$73.20M	-$1.65	N/A

Summary

Electromed beats Beta Bionics on 11 of the 16 factors compared between the two stocks.

How does Electromed compare to InMode?

Electromed (NYSE:ELMD) and InMode (NASDAQ:INMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

In the previous week, Electromed had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for Electromed and 2 mentions for InMode. Electromed's average media sentiment score of 1.29 beat InMode's score of 0.81 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

40.8% of Electromed shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

InMode has a net margin of 20.69% compared to Electromed's net margin of 11.34%. Electromed's return on equity of 15.71% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
InMode	20.69%	11.99%	10.60%

Electromed currently has a consensus target price of $43.75, indicating a potential upside of 57.78%. InMode has a consensus target price of $16.00, indicating a potential upside of 7.17%. Given Electromed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Electromed is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has higher revenue and earnings than Electromed. InMode is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.14	$5.15M	$1.31	21.17
InMode	$374.63M	2.29	$93.83M	$1.23	12.14

Electromed has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market. Comparatively, InMode has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

Summary

Electromed beats InMode on 11 of the 16 factors compared between the two stocks.

How does Electromed compare to SiBone?

Electromed (NYSE:ELMD) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Electromed presently has a consensus target price of $43.75, suggesting a potential upside of 57.78%. SiBone has a consensus target price of $24.17, suggesting a potential upside of 29.32%. Given Electromed's stronger consensus rating and higher possible upside, equities research analysts plainly believe Electromed is more favorable than SiBone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, SiBone had 2 more articles in the media than Electromed. MarketBeat recorded 6 mentions for SiBone and 4 mentions for Electromed. Electromed's average media sentiment score of 1.29 beat SiBone's score of 0.66 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SiBone	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Electromed has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.14	$5.15M	$1.31	21.17
SiBone	$200.93M	4.12	-$18.90M	-$0.34	N/A

Electromed has a net margin of 11.34% compared to SiBone's net margin of -6.85%. Electromed's return on equity of 15.71% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
SiBone	-6.85%	-8.23%	-6.07%

Electromed has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market. Comparatively, SiBone has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

40.8% of Electromed shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Electromed beats SiBone on 10 of the 16 factors compared between the two stocks.

How does Electromed compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

40.8% of Electromed shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Anteris Technologies Global presently has a consensus target price of $16.00, suggesting a potential upside of 84.44%. Electromed has a consensus target price of $43.75, suggesting a potential upside of 57.78%. Given Anteris Technologies Global's higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Electromed had 2 more articles in the media than Anteris Technologies Global. MarketBeat recorded 4 mentions for Electromed and 2 mentions for Anteris Technologies Global. Electromed's average media sentiment score of 1.29 beat Anteris Technologies Global's score of 0.89 indicating that Electromed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Electromed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Anteris Technologies Global has a beta of 1.8, suggesting that its share price is 80% more volatile than the broader market. Comparatively, Electromed has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

Electromed has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	442.65	-$94.14M	-$1.95	N/A
Electromed	$73.78M	3.14	$5.15M	$1.31	21.17

Electromed has a net margin of 11.34% compared to Anteris Technologies Global's net margin of -4,619.27%. Electromed's return on equity of 15.71% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats Anteris Technologies Global on 12 of the 16 factors compared between the two stocks.

How does Electromed compare to Varex Imaging?

Electromed (NYSE:ELMD) and Varex Imaging (NASDAQ:VREX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

In the previous week, Electromed had 1 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for Electromed and 3 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 1.77 beat Electromed's score of 1.29 indicating that Varex Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Varex Imaging	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

40.8% of Electromed shares are owned by institutional investors. 10.5% of Electromed shares are owned by insiders. Comparatively, 4.6% of Varex Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Electromed presently has a consensus target price of $43.75, indicating a potential upside of 57.78%. Varex Imaging has a consensus target price of $16.88, indicating a potential downside of 8.76%. Given Electromed's stronger consensus rating and higher probable upside, equities analysts clearly believe Electromed is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Varex Imaging	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Electromed has a net margin of 11.34% compared to Varex Imaging's net margin of 2.55%. Electromed's return on equity of 15.71% beat Varex Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Varex Imaging	2.55%	9.19%	4.13%

Electromed has higher earnings, but lower revenue than Varex Imaging. Electromed is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.14	$5.15M	$1.31	21.17
Varex Imaging	$844.60M	0.92	-$70.30M	$0.52	35.57

Electromed has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

Summary

Electromed beats Varex Imaging on 13 of the 16 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELMD vs. The Competition

Export

Metric	Electromed	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$231.57M	$5.50B	$7.18B	$23.38B
Dividend Yield	N/A	1.76%	2.54%	3.73%
P/E Ratio	36.91	25.12	270.94	28.94
Price / Sales	3.14	82.96	662.76	95.66
Price / Cash	41.36	32.95	77.07	33.53
Price / Book	5.44	6.34	10.91	4.77
Net Income	$5.15M	$150.94M	$3.48B	$1.07B
7 Day Performance	-1.81%	-1.69%	-1.04%	-0.39%
1 Month Performance	-34.28%	-0.38%	2.71%	-1.75%
1 Year Performance	4.21%	8.21%	22.24%	12.30%

Electromed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELMD Electromed	3.4704 of 5 stars	$27.73 +0.8%	$43.75 +57.8%	+10.2%	$231.57M	$73.78M	36.91	160	Positive News
BBNX Beta Bionics	1.3891 of 5 stars	$19.64 -1.6%	$20.10 +2.3%	-16.4%	$882.21M	$100.25M	N/A	294	Trending News
INMD InMode	1.4264 of 5 stars	$15.10 +0.9%	$16.00 +6.0%	-3.1%	$867.66M	$370.49M	12.27	480	News Coverage
SIBN SiBone	2.3691 of 5 stars	$18.83 -1.0%	$24.17 +28.3%	+15.4%	$834.22M	$200.93M	N/A	350
AVR Anteris Technologies Global	2.7526 of 5 stars	$8.43 -2.1%	$16.00 +89.7%	+85.8%	$824.02M	$1.91M	N/A	138	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELMD) was last updated on 9/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Electromed (ELMD) Competitors

ELMD vs. BBNX, INMD, SIBN, AVR, and VREX

How does Electromed compare to Beta Bionics?

Summary

How does Electromed compare to InMode?

Summary

How does Electromed compare to SiBone?

Summary

How does Electromed compare to Anteris Technologies Global?

Summary

How does Electromed compare to Varex Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Electromed (ELMD) Competitors

ELMD vs. BBNX, INMD, SIBN, AVR, and VREX

How does Electromed compare to Beta Bionics?

Do institutionals & insiders hold more shares of ELMD or BBNX?

Is ELMD or BBNX more profitable?

Which has more volatility & risk, ELMD or BBNX?

Do analysts rate ELMD or BBNX?

Does the media favor ELMD or BBNX?

Which has preferable valuation & earnings, ELMD or BBNX?

Summary

How does Electromed compare to InMode?

Does the media favor ELMD or INMD?

Do institutionals & insiders believe in ELMD or INMD?

Is ELMD or INMD more profitable?

Do analysts recommend ELMD or INMD?

Which has higher valuation and earnings, ELMD or INMD?

Which has more risk & volatility, ELMD or INMD?

Summary

How does Electromed compare to SiBone?

Do analysts recommend ELMD or SIBN?

Does the media prefer ELMD or SIBN?

Which has higher earnings and valuation, ELMD or SIBN?

Is ELMD or SIBN more profitable?

Which has more volatility and risk, ELMD or SIBN?

Do insiders and institutionals believe in ELMD or SIBN?

Summary

How does Electromed compare to Anteris Technologies Global?

Do insiders and institutionals hold more shares of AVR or ELMD?

Do analysts recommend AVR or ELMD?

Does the media prefer AVR or ELMD?

Which has more risk & volatility, AVR or ELMD?

Which has stronger earnings and valuation, AVR or ELMD?

Is AVR or ELMD more profitable?

Summary

How does Electromed compare to Varex Imaging?

Does the media favor ELMD or VREX?

Do institutionals and insiders have more ownership in ELMD or VREX?

Do analysts recommend ELMD or VREX?

Is ELMD or VREX more profitable?

Which has stronger earnings & valuation, ELMD or VREX?

Which has more risk & volatility, ELMD or VREX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools